Objective: The efficacy and tolerability of acarbose were examined in a postmarketing surveillance study of 27,803 patients with diabetes mellitus ... of a new drug. On the other hand, a ...
As expected, type 1 patients were younger, had a lower mean body mass index, and had a longer mean diabetes duration ... concomitant medication was received by 81% of acarbose and 86% of placebo ...
A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...
Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently ...
Synex Medical just raised $21.8 million to build a portable MRI capable of testing glucose and other important molecules ...
A recent study has revealed that certain medications used to treat type 2 diabetes may offer protection against dementia and Alzheimer’s disease (AD). The research, published in the American ...
Which type 2 diabetes treatment is right for you? If lifestyle changes alone don’t allow you to meet your blood sugar and A1C goals, your doctor may prescribe medication. Here are some factors ...
Though Habener didn't realize its significance at the time, this turned out to be the fish-equivalent of "GLP-1," the foundation for today's diabetes and obesity drugs. "That's what's beautiful ...
Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Replacing Ultra-Processed Foods in Diet Reduces Type ...
Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care ...
Share on Pinterest Some drugs used to treat type 2 diabetes could also help lower a person’s risk of neurodegenerative diseases, such as Alzheimer’s. Image credit: martin-dm/Getty Images.